Xuan Kang, MD
Psychiatry · Aurora, CONPI 1144614173
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 212 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 36.1% of the total. 2025 is the largest year on record at $1,237, 6.2 times the $199 reported in 2020. Among psychiatry clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 212 payments — averaging $22.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Argenx US, Inc.$508
- Biohaven Pharmaceuticals, Inc.$371
- Pfizer$303
- Biohaven Pharmaceutical Holding Company Ltd.$265
- Teva Pharmaceuticals USA, Inc.$241
- plus $1K from 21 others
What the payments were for
- Food & beverage$4,846100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 91 | $1,748 |
| Argenx US, Inc. | 15 | $508 |
| Biohaven Pharmaceuticals, Inc. | 15 | $371 |
| Pfizer | 9 | $303 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $265 |
| Teva Pharmaceuticals USA, Inc. | 10 | $241 |
| Lilly USA, LLC | 11 | $197 |
| Tanabe Pharma America, Inc. | 6 | $137 |
| Merz Pharmaceuticals, LLC | 5 | $116 |
| Scilex Pharmaceuticals Inc. | 6 | $111 |
| Genentech USA, Inc. | 4 | $108 |
| UCB, Inc. | 3 | $107 |
| Jazz Pharmaceuticals Inc. | 5 | $101 |
| Harmony Biosciences LLC | 3 | $81 |
| Ascendis Pharma Endocrinology Inc | 2 | $73 |
| Novartis | 3 | $66 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Impel Pharmaceuticals Inc. | 2 | $42 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $40 |
| Catalyst Pharmaceuticals, Inc. | 1 | $36 |
| Bioventus LLC | 2 | $31 |
| Averitas Pharma Inc. | 1 | $27 |
| Kedrion Biopharma Inc. | 1 | $24 |
| Vertex | 1 | $20 |
| Biogen | 1 | $18 |
| Janssen Scientific Affairs, LLC | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$122
- NURTEC ODT$102
How this compares
$4,846 in reported general payments places this provider in the 90th percentile of 559 psychiatry providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 34 | $537,324 |
| GammakedImmune Globul G/Gly/Iga Avg 46 | 24 | $437,403 |
| Nurtec OdtRimegepant Sulfate | 43 | $51,652 |
| Emgality PenGalcanezumab-Gnlm | 12 | $20,795 |
| UbrelvyUbrogepant | 17 | $18,601 |
| Gabapentin | 172 | $5,973 |
| Lidocaine | 17 | $4,253 |
| Carbamazepine ErCarbamazepine | 17 | $2,339 |
| Pyridostigmine Bromide | 25 | $1,566 |
| Baclofen | 62 | $1,257 |
| Pregabalin | 40 | $1,017 |
| Duloxetine Hcl | 31 | $921 |
| Nortriptyline Hcl | 30 | $918 |
| Oxcarbazepine | 17 | $904 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 31 | $902 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerNurtec Odt | $303 | $51,65243 claims |
| AbbVieUbrelvy | $1,748 | $18,60117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 559 psychiatry providers in Colorado.
Other psychiatry in Aurora
- Cynthia EppersonAurora$64K
- Eric FrenchAurora$10K
- Rachel DavisAurora$6K
- Kerri LangerAurora$4K
- Andrew NovickAurora$3K
- Michael AllenAurora$2K
- John HardyPueblo$828K
- Larry SandersLittleton$760K
- Jeffrey RichmondDenver$424K
- Jennifer FrenchGlendale$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.